https://stock.noler.com/us/stock/gala-pharmaceutical-inc https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accounts-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accretion-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/accumulated-depreciation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/acquisition-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/additional-paid-in-capital https://stock.noler.com/us/stock/gala-pharmaceutical-inc/adjustment-for-amortization https://stock.noler.com/us/stock/gala-pharmaceutical-inc/advertising-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/allowance-for-doubtful-other-receivables-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/allowance-for-loan-and-lease-losses-write-offs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/gala-pharmaceutical-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/gala-pharmaceutical-inc/assets-noncurrent https://stock.noler.com/us/stock/gala-pharmaceutical-inc/bank-overdrafts https://stock.noler.com/us/stock/gala-pharmaceutical-inc/basic-shares https://stock.noler.com/us/stock/gala-pharmaceutical-inc/capital-expenditures https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cash https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cash-and-equivalents https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cash-change https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cash-flow-breakdown https://stock.noler.com/us/stock/gala-pharmaceutical-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/gala-pharmaceutical-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/gala-pharmaceutical-inc/commitments-and-contingencies https://stock.noler.com/us/stock/gala-pharmaceutical-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gala-pharmaceutical-inc/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/gala-pharmaceutical-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/gala-pharmaceutical-inc/common-stock-value https://stock.noler.com/us/stock/gala-pharmaceutical-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/gala-pharmaceutical-inc/convertible-notes-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cost-of-revenue https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cost-of-services-environmental-remediation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/costs-and-expenses-related-party https://stock.noler.com/us/stock/gala-pharmaceutical-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/gala-pharmaceutical-inc/current-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/gala-pharmaceutical-inc/current-liabilities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-face-amount https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/gala-pharmaceutical-inc/debt-unamortized-discount https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-compensation-equity https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-rent-credit https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/gala-pharmaceutical-inc/deposits-assets-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/depreciation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/depreciation-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/derivative-cost-of-hedge https://stock.noler.com/us/stock/gala-pharmaceutical-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/gala-pharmaceutical-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/derivative-liabilities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/derivative-liabilities-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/gala-pharmaceutical-inc/due-from-related-parties https://stock.noler.com/us/stock/gala-pharmaceutical-inc/due-to-related-parties-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/gala-pharmaceutical-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/gala-pharmaceutical-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/gala-pharmaceutical-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-change https://stock.noler.com/us/stock/gala-pharmaceutical-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-gain-loss-included-in-earnings https://stock.noler.com/us/stock/gala-pharmaceutical-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/gala-pharmaceutical-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-settlements https://stock.noler.com/us/stock/gala-pharmaceutical-inc/financing-cash-flow https://stock.noler.com/us/stock/gala-pharmaceutical-inc/financing-interest-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/financing-receivables-impaired-troubled-debt-restructuring-write-down https://stock.noler.com/us/stock/gala-pharmaceutical-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gain-loss-on-sale-of-notes-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gain-loss-on-sale-of-stock-in-subsidiary-or-equity-method-investee https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gain-or-loss-on-sale-of-stock-in-subsidiary https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/general-and-administrative-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/gross-profit https://stock.noler.com/us/stock/gala-pharmaceutical-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/gala-pharmaceutical-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-loss-from https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-tax https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-tax-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-taxes-paid https://stock.noler.com/us/stock/gala-pharmaceutical-inc/income-taxes-paid-2 https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-book-overdrafts https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-deferred-compensation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-deposits https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-notes-receivable-related-parties https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-payables-to-broker-dealers https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/gala-pharmaceutical-inc/insider-transactions-preferred https://stock.noler.com/us/stock/gala-pharmaceutical-inc/interest-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/interest-income-other https://stock.noler.com/us/stock/gala-pharmaceutical-inc/interest-paid https://stock.noler.com/us/stock/gala-pharmaceutical-inc/interest-paid-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/interest-receivable-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/inventory https://stock.noler.com/us/stock/gala-pharmaceutical-inc/inventory-write-down https://stock.noler.com/us/stock/gala-pharmaceutical-inc/investing-cash-flow https://stock.noler.com/us/stock/gala-pharmaceutical-inc/investment-income-interest https://stock.noler.com/us/stock/gala-pharmaceutical-inc/investments-in-affiliates-subsidiaries-associates-and-joint-ventures https://stock.noler.com/us/stock/gala-pharmaceutical-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/gala-pharmaceutical-inc/lease-and-rental-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/litigation-settlement-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/loans-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/loans-payable-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/management-fee-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/marketable-securities-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/marketable-securities-gain-loss https://stock.noler.com/us/stock/gala-pharmaceutical-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/gala-pharmaceutical-inc/minority-interest https://stock.noler.com/us/stock/gala-pharmaceutical-inc/net-change-in-cash https://stock.noler.com/us/stock/gala-pharmaceutical-inc/net-income https://stock.noler.com/us/stock/gala-pharmaceutical-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/gala-pharmaceutical-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/gala-pharmaceutical-inc/noninterest-expense-transfer-agent-and-custodian-fees https://stock.noler.com/us/stock/gala-pharmaceutical-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-cash-flow https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-expenses https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-income https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-income https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-noncash-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-nonoperating-income https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/paid-in-capital-other https://stock.noler.com/us/stock/gala-pharmaceutical-inc/paid-in-capital-share-based-compensation-other-longterm-incentive-plans-requisite-service-period-recognition https://stock.noler.com/us/stock/gala-pharmaceutical-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/gala-pharmaceutical-inc/partners-capital-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-to-acquire-finance-receivables https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-to-acquire-interest-in-joint-venture https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-to-acquire-loans-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-shares-facts https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/gala-pharmaceutical-inc/preferred-stock-value https://stock.noler.com/us/stock/gala-pharmaceutical-inc/prepaid-expense-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/pretax-income-domestic https://stock.noler.com/us/stock/gala-pharmaceutical-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-collection-of-loans-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-repayments-of-bank-overdrafts https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/gala-pharmaceutical-inc/professional-and-contract-services-expense https://stock.noler.com/us/stock/gala-pharmaceutical-inc/professional-fees https://stock.noler.com/us/stock/gala-pharmaceutical-inc/profit-loss https://stock.noler.com/us/stock/gala-pharmaceutical-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/gala-pharmaceutical-inc/property-plant-equipment https://stock.noler.com/us/stock/gala-pharmaceutical-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/gala-pharmaceutical-inc/public-float https://stock.noler.com/us/stock/gala-pharmaceutical-inc/related-party-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/gala-pharmaceutical-inc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/gala-pharmaceutical-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/gala-pharmaceutical-inc/retained-earnings https://stock.noler.com/us/stock/gala-pharmaceutical-inc/revenue https://stock.noler.com/us/stock/gala-pharmaceutical-inc/revenue-from-related-parties https://stock.noler.com/us/stock/gala-pharmaceutical-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/gala-pharmaceutical-inc/sales-revenue-net https://stock.noler.com/us/stock/gala-pharmaceutical-inc/settlement-liabilities-current https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shareholders-equity https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shares-authorized https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shares-issued https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/gala-pharmaceutical-inc/shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/gala-pharmaceutical-inc/short-term-non-bank-loans-and-notes-payable https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-based-compensation https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/gala-pharmaceutical-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/gala-pharmaceutical-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/gala-pharmaceutical-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/gala-pharmaceutical-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/gala-pharmaceutical-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/gala-pharmaceutical-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/gala-pharmaceutical-inc/technology-services-costs https://stock.noler.com/us/stock/gala-pharmaceutical-inc/total-assets https://stock.noler.com/us/stock/gala-pharmaceutical-inc/total-liabilities https://stock.noler.com/us/stock/gala-pharmaceutical-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/gala-pharmaceutical-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/gala-pharmaceutical-inc/weighted-average-number-of-share-outstanding-basic-and-diluted